Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease
Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV
Department of Radiation Oncology, M.D. Anderson Cancer Center Orlando, Orlando, FL, USA. Electronic address: .